A detailed history of Sterling Capital Management LLC transactions in Precigen, Inc. stock. As of the latest transaction made, Sterling Capital Management LLC holds 602 shares of PGEN stock, worth $1,992. This represents 0.0% of its overall portfolio holdings.

Number of Shares
602
Previous 2,151 72.01%
Holding current value
$1,992
Previous $3.21 Million 73.32%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 06, 2025

SELL
$1.17 - $1.62 $1,812 - $2,509
-1,549 Reduced 72.01%
602 $855,000
Q1 2025

May 13, 2025

SELL
$1.07 - $2.03 $1,946 - $3,692
-1,819 Reduced 45.82%
2,151 $3.21 Million
Q4 2024

Feb 13, 2025

BUY
$0.67 - $1.12 $2,405 - $4,020
3,590 Added 944.74%
3,970 $4.45 Million
Q3 2024

Nov 12, 2024

BUY
$0.91 - $1.88 $345 - $714
380 New
380 $360,000

Others Institutions Holding PGEN

About PRECIGEN, INC.


  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $689M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track This Portfolio

Track Sterling Capital Management LLC Portfolio

Follow Sterling Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sterling Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sterling Capital Management LLC with notifications on news.